JackRothMD

Cardiovascular Surgery

Professor of Thoracic Surgery, University Tex Houston

Dr. Roth is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Thoracic Surgery, 1977 - 1980
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 1975 - 1977
Johns Hopkins University School of MedicineInternship, Transitional Year, 1971 - 1972
Johns Hopkins University School of MedicineClass of 1971

PubMed

2 citations
Mechanisms of Response and Tolerance to Active RAS Inhibition in KRAS-Mutant Non-Small Cell Lung Cancer.
Haniel A Araujo, Ximo Pechuan-Jorge, Teng Zhou, Minh Truong Do, Xin Hu
Cancer Discovery. 2024-11-01
1 citations
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, Yu Qian, Xin Sun
Nature. 2024-11-01
Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer.
Nicolas Zhou, Cheuk H Leung, William N William Jr, Annikka Weissferdt, Apar Pataer
Journal for Immunotherapy of Cancer. 2024-10-23

Journal Articles

Inhibition of thioredoxin/thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis
John V Heymach, Stephen G Swisher, Jack A Roth, John D Minna, Clinical Cancer Research
Landscape of EGFR -Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Post-Progression in EGFR-Mutant NSCLC
Stephen G Swisher, Vassiliki A Papadimitrakopoulou, John V Heymach, Jack A Roth, Jianjun Zhang, William N William, Bonnie S Glisson, Clinical Cancer Research
Validation of the 12-Gene Predictive Signature for Adjuvant Chemotherapy Response in Lung Cancer
Cesar Moran, Jack A Roth, Yang Xie, John D Minna, Vassiliki A Papadimitrakopoulou, John V Heymach, Stephen G Swisher, Clinical Cancer Research

Long-Term Benefit of SABR for Operable Early-Stage NSCLC Shown in New StudySeptember 13th, 2021
How Genprex Took an Abandoned Pipeline Drug and Turned It into Oncoprex, an Innovative Treatment for Non-Small Cell Lung CancerOctober 17th, 2018
Genprex Reports New Pre-Clinical Data Showing Strong Anti-Tumor Effect of TUSC2 in Combination with PD-1 Checkpoint Blockade in Lung CancerApril 2nd, 2017
Join now to see all

P-5: Translation Of The 3p21.3 Gene FUS1 Into Pathway-Targeted Molecular TherapyNational Cancer Institute2008–2011
Developmental Research ProgramNational Cancer Institute2008–2011
Career Development ProgramNational Cancer Institute2008–2011
Restoration Of Apoptosis In CancerNational Cancer Institute1999–2003
Radiation Sensitivity/Apoptosis Induction In Cancer Cells--P53 RestorationNational Cancer Institute1999–2002
Modification Of Oncogene ExpressionNational Cancer Institute1992–1994
Training Of Academic Thoracic Surgical OncologistsNational Cancer Institute1988–1992
Tumor Antigens Expressed By Oncogene-Transformed CellsNational Cancer Institute1987–1991